Clinical Trial

Effects of H. Pylori Eradication on the Gastric Preneoplastic Lesion and Neoplasm After ESD

Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This study evaluates whether Helicobacter pylori eradication improves precancerous lesions including glandular atrophy and intestinal metaplasia as well as metachronous cancers or dysplasias after endoscopic mucosal resection for gastric cancer.
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2015-04-01; most recent amendment 2023-11-07.
Trial Details
NCT Number NCT02407119
Lead Sponsor National Cancer Center, Korea
Conditions Helicobacter Pylori Infection, Early Gastric Cancer, Endoscopic Resection
Enrollment 470 participants
Start Date 2003-06
Primary Completion 2016-06 (estimated)
Study Completion 2030-06 (estimated)
Updated on ClinicalTrials.gov 2023-11-09